Should Immune-Enhancing Formulations Be Used for Patients With Acute Respiratory Distress Syndrome?

about

Modulation of Haemophilus influenzae interaction with hydrophobic molecules by the VacJ/MlaA lipoprotein impacts strongly on its interplay with the airways.

P2860

Q55347367-786F09B9-0729-4573-8775-1F4FE1265D89

P2860

Should Immune-Enhancing Formulations Be Used for Patients With Acute Respiratory Distress Syndrome?

Item

http://www.wikidata.org/entity/Q38875187

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Should Immune-Enhancing Formul ...... Respiratory Distress Syndrome?

@en

type

Item

label

Should Immune-Enhancing Formul ...... Respiratory Distress Syndrome?

@en

prefLabel

Should Immune-Enhancing Formul ...... Respiratory Distress Syndrome?

@en

P1476

Should Immune-Enhancing Formul ...... Respiratory Distress Syndrome?

@en

P2093

Hannah Roosevelt

http://www.w3.org/2001/XMLSchema#string

P2860

Enteral Immunomodulatory Diet (Omega-3 Fatty Acid, γ-Linolenic Acid and Antioxidant Supplementation) for Acute Lung Injury and Acute Respiratory Distress Syndrome: An Updated Systematic Review and Meta-Analysis

Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury

Initial trophic vs full enteral feeding in patients with acute lung injury: the EDEN randomized trial.

The use of an inflammation-modulating diet in patients with acute lung injury or acute respiratory distress syndrome: a meta-analysis of outcome data.

Update in acute respiratory distress syndrome

Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis.

Enteral omega-3 fatty acid supplementation in adult patients with acute respiratory distress syndrome: a systematic review of randomized controlled trials with meta-analysis and trial sequential analysis.

Pathophysiology and biomarkers of acute respiratory distress syndrome.

Early parenteral nutrition in critically ill patients with short-term relative contraindications to early enteral nutrition: a randomized controlled trial.

Early Treatment of Severe Acute Respiratory Distress Syndrome.

P304

451-456

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0884533616654868

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27339156

http://www.w3.org/2001/XMLSchema#string

P921

acute respiratory distress syndrome

Should Immune-Enhancing Formulations Be Used for Patients With Acute Respiratory Distress Syndrome?

about

P2860

P2860

Should Immune-Enhancing Formulations Be Used for Patients With Acute Respiratory Distress Syndrome?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921